Experienced in Teratoma of the Mediastinum

Fanny Fouyssac

Vandoeuvre-les-nancy, FR 
Experienced in Teratoma of the Mediastinum
Vandoeuvre-les-nancy, FR 
OverviewLocationsClinical Research

Overview

Fanny Fouyssac practices in Vandoeuvre-les-nancy, France. Ms. Fouyssac is rated as an Experienced expert by MediFind in the treatment of Teratoma of the Mediastinum. Her top areas of expertise are Evans Syndrome, Chronic Granulomatous Disease, Autoimmune Hemolytic Anemia, Sideroblastic Anemia, and Splenectomy.

Her clinical research consists of co-authoring 45 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Teratoma of the Mediastinum.

Gender
Female

Locations

Vandoeuvre-les-nancy, France
Other Locations
Nancy, France
Paris, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase I Study of Fluvastatin-Celebrex Association for Optico-chiasmatic Low Grade Gliomas and High Grade Gliomas Localized Outside the Brainstem, Relapsed or Refactory, in Children or Young Adults
Phase I Study of Fluvastatin-Celebrex Association for Optico-chiasmatic Low Grade Gliomas and High Grade Gliomas Localized Outside the Brainstem, Relapsed or Refactory, in Children or Young Adults
Enrollment Status: Completed
Publish Date: February 10, 2022
Intervention Type: Drug
Study Drugs: Fluvastatine, Celebrex
Study Phase: Phase 1
Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma
Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma
Enrollment Status: Completed
Publish Date: November 18, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

45 Total Publications

CXCR4 Antagonist in HPV5-Associated Perianal Squamous-Cell Carcinoma.
CXCR4 Antagonist in HPV5-Associated Perianal Squamous-Cell Carcinoma.
Journal: The New England journal of medicine
Published: April 10, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Fouyssac's expertise for a condition
ConditionClose
      View All 31 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile